Scotiabank analyst Sung Ji Nam maintained a Buy rating on Adaptive Biotechnologies (ADPT – Research Report) today and set a price target of $10.00. The company’s shares closed yesterday at $6.49.

Oct. 23, 2024 /CNW/ - Scotiabank announced today that it is decreasing its Canadian dollar prime lending rate to 5.95 from 6.45, effective October 24, 2024. Scotiabank Logo (CNW Group/Scotiabank) ...

The game will feature the debut of Kenzie Lalonde on Canadian Tire Senators Hockey on TSN. Lalonde is part of a trio of ...

Scotiabank analyst Nick Altmann raised the firm’s price ... large platform deals starting to move the needle on bookings and believes more referenceable logos will drive pipeline conversion. Published ...

It was the third straight game in which Toronto had scored at least two power-play goals. The Maple Leafs were 3-for-42 on ...

Weeks joined Scotiabank in September 2021 as executive vice president, Retail Customer. Riley joined the Canadian lender in 1994 and since then has held several senior executive positions in its ...

Former Toronto Raptors player Vince Carter had his No. 15 jersey retired by the franchise on Saturday night in an emotional ceremony at Scotiabank Arena ...

Scotiabank logo (CNW Group/Scotiabank - Sponsorships & Donations) The agreement aims to enhance opportunities for cardiovascular professionals to access further education, enrich research ...

Frequent flyers will love the Scotiabank Passport Visa Infinite credit card’s travel perks and lack of foreign transaction fee, but they may be overwhelmed by everything else. The Scotiabank ...

Financial results will be issued in a press release at approximately 6:00 a.m. ET on Tuesday, December 3, 2024. The results will be available on Scotiabank's Investor ...